Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.89
Delayed Data
As of 4:00pm ET
 +0.09 / +2.37%
Today’s Change
1.17
Today|||52-Week Range
6.55
-9.11%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close3.80
Today’s open3.83
Day’s range3.72 - 3.93
Volume270,850
Average volume (3 months)2,425,914
Market cap$161.8M
Data as of 4:00pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)-19.23%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...+0.06+1.58%
ATXIAvenue Therapeutics ...-0.24-5.97%
XENEXenon Pharmaceutical...+0.10+3.70%
APDNApplied DNA Sciences...-0.02-1.34%
Data as of 4:00pm ET, 01/17/2018

Financials

Next reporting dateFebruary 26, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts